Home › Bristol-Myers' Opdivo found effective in kidney cancer
 

Keywords :   


Bristol-Myers' Opdivo found effective in kidney cancer

2015-07-20 17:36:34| Biotech - Topix.net

Bristol-Myers Squibb Co said a late-stage trial of its drug, Opdivo, was stopped early after the immunotherapy was found to be effective in patients with the most common form of kidney cancer. The U.S. drugmaker said on Monday the study, Checkmate-025, was stopped early after an independent data monitoring committee concluded that Opdivo provided a survival advantage over the cancer drug, everolimus, among patients with advanced or metastatic renal cell carcinoma.

Tags: found effective cancer kidney

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Flint Group retains EcoVadis Silver Medal for 2024
15.05Mark Andy hosts student workshop in Poland
15.05Kenvue Launches Aveeno Baby Healthy Start Wash and Balm
15.05Royal Mail owner poised to accept 3.5bn takeover bid
15.05Gold Bond Named Official Body Skin Sponsor of Sports Illustrated Swimsuit\'s 60th Anniversary Issue
15.05Dunn-Edwards Reveals New Multifamily Color Collection
15.05Kimberly-Clark Names Chief Growth Officer
15.05TV Personality Lo Bosworth and BIC Soleil Escape Razors Launch Limited-Edition Five Senses Shave Kit
More »